Stemline Therapeutics (NASDAQ: STML) athat it intends to offer and sell shares of its common stock in an underwritten public ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE